Be Ready to Prescribe Alternatives to Valsartan
September 2018
The valsartan recall will continue to raise questions about how to switch to a different ARB or an ACE inhibitor.
The generic products impacted are a moving target. For now, the recall also includes some combos with hydrochlorothiazide or amlodipine.
The recalled products may have been contaminated with the probable carcinogen N-nitrosodimethylamine (NDMA) for as long as 4 years...possibly because of changes in how valsartan was made.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote